Komori
Occurring Fact3151VITAL KSK HOLDINGS,INC.Trading & Wholesale

Notice Regarding the Recording of a Gain on Sale of Investment Securities (Extraordinary Income)

The company disclosed that 2 consolidated subsidiaries have decided to sell part of their listed shares between 28 July 2026 and 31 March 2027, and expect to record a gain on sale of ¥8.1 billion. The full-year earnings forecast for the fiscal year ending March 2027 remains unchanged at this time.

Worth reading
38Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
8100
¥ million (consolidated, estimated)
Wording
Conditional
How definitive the wording is.

Recognition of Gain on Sale of Investment Securities (Extraordinary Income)

Subject Entity

2 consolidated subsidiaries of the company (names not disclosed)

Target Locations / Products

Listed shares

Occurrence27 July 2026 (date of board resolution)
This disclosure07/27/2026
Cause

To review policy-held shares, use assets more efficiently, and strengthen the financial position

Amount of Impact on Business Performance

Gain on sale of investment securities (extraordinary gain): ¥8,100 million (consolidated, estimated)

Accounting period in which recognized

Full fiscal year ending March 2027

Impact on Earnings Forecast

The consolidated full-year earnings forecast for the fiscal year ending March 2027 remains unchanged at this time. The company will promptly disclose any revision if one becomes necessary.

Outlook

The sale period is from 28 July 2026 to 31 March 2027. The company will promptly disclose any revision if one becomes necessary.

Event that occurred
ItemDetails
Event nameRecognition of Gain on Sale of Investment Securities (Extraordinary Income)
Date of occurrence27 July 2026 (date of board resolution)
Subject Entity2 consolidated subsidiaries of the company (names not disclosed)
Target Locations / ProductsListed shares
CauseTo review policy-held shares, use assets more efficiently, and strengthen the financial position
Amount of Impact on Business PerformanceGain on sale of investment securities (extraordinary gain): ¥8,100 million (consolidated, estimated)
Accounting period in which recognizedFull fiscal year ending March 2027
Impact on Earnings ForecastThe consolidated full-year earnings forecast for the fiscal year ending March 2027 remains unchanged at this time. The company will promptly disclose any revision if one becomes necessary.
OutlookThe sale period is from 28 July 2026 to 31 March 2027. The company will promptly disclose any revision if one becomes necessary.
Planned follow-up disclosureThe company will promptly disclose any revision if one becomes necessary.
Items this document does not state (15)
Date recognized / date notice receivedType of litigation or proceedingCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityVoting rights ownership percentage before the changeVoting rights ownership percentage after the change

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To review its policy-held shares, use its assets more efficiently, and strengthen its financial position.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Recording of a Gain on Sale of Investment Securities (Extraordinary Income) | VITAL KSK HOLDINGS,INC. (3151) timely disclosure | Komori